Your browser doesn't support javascript.
loading
Best Practices and Guidelines (2022) for Scale-up and Technology Transfer in Freeze Drying Based on Case Studies. Part 2: Past Practices, Current Best Practices, and Recommendations.
Tchessalov, Serguei; Shalaev, Evgenyi; Bhatnagar, Bakul; Nail, Steven; Alexeenko, Alina; Jameel, Feroz; Srinivasan, Jayasree; Dekner, Michael; Sahni, Ekneet; Schneid, Stefan; Kazarin, Petr; McGarvey, Orla; Van Meervenne, Bert; Kshirsagar, Vaibhav; Pande, Paritosh; Philipp, Jens; Sacha, Greg; Wu, Ke; Azzarella, Joseph; Shivkumar, Gayathri; Bhatt, Shreyas; Mehta, Shyam B.
Afiliação
  • Tchessalov S; Pfizer Inc., Andover, Massachusetts, USA.
  • Shalaev E; AbbVie, Irvine, California, USA.
  • Bhatnagar B; Pfizer Inc., Andover, Massachusetts, USA.
  • Nail S; Consultant, West Lafayette, Indiana, USA.
  • Alexeenko A; Birck Nanotechnology Center, Purdue University, 1205 W State St., West Lafayette, Indiana, 47907, USA.
  • Jameel F; Consultant, West Lafayette, Indiana, USA.
  • Srinivasan J; Baxter, Bloomington, Indiana, USA.
  • Dekner M; Takeda Pharmaceutical Company, Vienna, Austria.
  • Sahni E; Pfizer Inc., McPherson, Kansas, USA.
  • Schneid S; Bayer, Wuppertal, Germany.
  • Kazarin P; Birck Nanotechnology Center, Purdue University, 1205 W State St., West Lafayette, Indiana, 47907, USA. pkazarin@purdue.edu.
  • McGarvey O; Lonza AG, Basel, Switzerland.
  • Van Meervenne B; Pfizer Inc., Temse, Belgium.
  • Kshirsagar V; IMA Life, Tonawanda, New York, USA.
  • Pande P; Merck & Co., Inc., Rahway, New Jersey, USA.
  • Philipp J; OPTIMA Pharma, Gladenbach, Hesse, Germany.
  • Sacha G; Baxter, Bloomington, Indiana, USA.
  • Wu K; AbbVie, Irvine, California, USA.
  • Azzarella J; Fresenius Kabi, Grand Island, New York, USA.
  • Shivkumar G; AbbVie Inc., North Chicago, Illinois, USA.
  • Bhatt S; OPTIMA Pharma, Gladenbach, Hesse, Germany.
  • Mehta SB; Teva Pharmaceuticals, West Chester, Pennsylvania, USA.
AAPS PharmSciTech ; 24(4): 96, 2023 Apr 03.
Article em En | MEDLINE | ID: mdl-37012545
ABSTRACT
Scale-up and transfer of lyophilization processes remain very challenging tasks considering the technical challenges and the high cost of the process itself. The challenges in scale-up and transfer were discussed in the first part of this paper and include vial breakage during freezing at commercial scale, cake resistance differences between scales, impact of differences in refrigeration capacities, and geometry on the performance of dryers. The second part of this work discusses successful and unsuccessful practices in scale-up and transfer based on the experience of the authors. Regulatory aspects of scale-up and transfer of lyophilization processes were also outlined including a topic on the equivalency of dryers. Based on an analysis of challenges and a summary of best practices, recommendations on scale-up and transfer of lyophilization processes are given including projections on future directions in this area of the freeze drying field. Recommendations on the choice of residual vacuum in the vials were also provided for a wide range of vial capacities.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tecnologia Farmacêutica / Transferência de Tecnologia / Liofilização Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tecnologia Farmacêutica / Transferência de Tecnologia / Liofilização Idioma: En Ano de publicação: 2023 Tipo de documento: Article